Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline Solution in Acute Decompensated Heart Failure
NCT05298098Unknown
- Sponsor
- Université de Monastir
- Start
- Jul 2018
- Primary completion
- Sep 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, double-blind trial of hypertonic saline in heart failure (HF) (2 arms), sponsored by Université de Monastir. Primary endpoints: Length of Hospital Stay at 1 week, In-hospital mortality at 1 week and 2 more. Status: unknown.
02
Drugs
hypertonic saline
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05298098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05298098.